Avidumicin, a novel cyclic bacteriocin, produced by Cutibacterium avidum shows anti-Cutibacterium acnes activity

Nakase K, Aoki S, Sei S, Fukumoto S, Horiuchi Y, Yasuda T, et al. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study. J Dermatol. 2020;47:863–9.

Article  CAS  PubMed  Google Scholar 

Hayashi N, Akamatsu H, Iwatsuki K, Shimada-Omori R, Kaminaka C, Kurokawa I, et al. Japanese dermatological association guidelines: Guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018;45:898–935.

Article  PubMed  Google Scholar 

Nakase K, Hayashi N, Akiyama Y, Aoki S, Noguchi N. Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015. J Dermatol. 2017;44:1248–54.

Article  CAS  PubMed  Google Scholar 

Sardana K, Gupta T, Garg VK, Ghunawat S. Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management. Expert Rev Anti Infect Ther. 2015;13:883–96.

Article  CAS  PubMed  Google Scholar 

Nakase K, Yoshida A, Saita H, Hayashi N, Nishijima S, Nakaminami H, et al. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris. J Dermatol. 2019;46:782–6.

Article  CAS  PubMed  Google Scholar 

Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol. 2013;21:660–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc. 2001;6:170–4.

Article  CAS  PubMed  Google Scholar 

O’Sullivan JN, Rea MC, O’Connor PM, Hill C, Ross RP. Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens. FEMS Microbiol Ecol. 2019;95:fiy241.

PubMed  Google Scholar 

Khalfallah G, Gartzen R, Moller M, Heine E, Lutticken R. A new approach to harness probiotics against common bacterial skin pathogens: Towards living antimicrobials. Probiot Antimicrob Proteins. 2021;13:1557–71.

Article  CAS  Google Scholar 

Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol. 2002;110:823–31.

Article  CAS  PubMed  Google Scholar 

Khelissa S, Chihib NE, Gharsallaoui A. Conditions of nisin production by Lactococcus lactis subsp. lactis and its main uses as a food preservative. Arch Microbiol. 2021;203:465–80.

Article  CAS  PubMed  Google Scholar 

Gotz F, Perconti S, Popella P, Werner R, Schlag M. Epidermin and gallidermin: Staphylococcal lantibiotics. Int J Med Microbiol. 2014;304:63–71.

Article  PubMed  Google Scholar 

Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9:244–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenthal M, Goldberg D, Aiello A, Larson E, Foxman B. Skin microbiota: microbial community structure and its potential association with health and disease. Infect Genet Evol. 2011;11:839–48.

Article  PubMed  PubMed Central  Google Scholar 

Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M, Noguchi N. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. J Med Microbiol. 2014;63:721–8.

Article  CAS  PubMed  Google Scholar 

Aoki S, Nakase K, Hayashi N, Noguchi N. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes. J Med Microbiol. 2019;68:26–30.

Article  CAS  PubMed  Google Scholar 

Nakase K, Okamoto Y, Aoki S, Noguchi N. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes. J Dermatol. 2018;45:340–3.

Article  CAS  PubMed  Google Scholar 

Perez RH, Sugino H, Ishibashi N, Zendo T, Wilaipun P, Leelawatcharamas V, et al. Mutations near the cleavage site of enterocin NKR-5-3B prepeptide reveal new insights into its biosynthesis. Microbiology. 2017;163:431–41.

Article  CAS  PubMed  Google Scholar 

Grande Burgos MJ, Pulido RP, Del Carmen Lopez Aguayo M, Galvez A, Lucas R. The cyclic antibacterial peptide enterocin AS-48: Isolation, mode of action, and possible food applications. Int J Mol Sci. 2014;15:22706–27.

Article  PubMed  PubMed Central  Google Scholar 

Wirawan RE, Swanson KM, Kleffmann T, Jack RW, Tagg JR. Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. Microbiology. 2007;153:1619–30.

Article  CAS  PubMed  Google Scholar 

Masuda Y, Ono H, Kitagawa H, Ito H, Mu F, Sawa N, et al. Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401. Appl Environ Microbiol. 2011;77:8164–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin-Visscher LA, van Belkum MJ, Garneau-Tsodikova S, Whittal RM, Zheng J, McMullen LM, et al. Isolation and characterization of carnocyclin A, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307. Appl Environ Microbiol. 2008;74:4756–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sawa N, Zendo T, Kiyofuji J, Fujita K, Himeno K, Nakayama J, et al. Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by Lactococcus sp. strain QU 12. Appl Environ Microbiol. 2009;75:1552–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemperman R, Kuipers A, Karsens H, Nauta A, Kuipers O, Kok J. Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574. Appl Environ Microbiol. 2003;69:1589–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalmokoff ML, Cyr TD, Hefford MA, Whitford MF, Teather RM. Butyrivibriocin AR10, a new cyclic bacteriocin produced by the ruminal anaerobe Butyrivibrio fibrisolvens AR10: characterization of the gene and peptide. Can J Microbiol. 2003;49:763–73.

Article  CAS  PubMed  Google Scholar 

Kawai Y, Kemperman R, Kok J, Saito T. The circular bacteriocins gassericin A and circularin A. Curr Protein Pept Sci. 2004;5:393–8.

Article  CAS  PubMed  Google Scholar 

Scholz R, Vater J, Budiharjo A, Wang Z, He Y, Dietel K, et al. Amylocyclicin, a novel circular bacteriocin produced by Bacillus amyloliquefaciens FZB42. J Bacteriol. 2014;196:1842–52.

Article  PubMed  PubMed Central  Google Scholar 

Potter A, Ceotto H, Coelho MLV, Guimaraes AJ, Bastos M. The gene cluster of aureocyclicin 4185: the first cyclic bacteriocin of Staphylococcus aureus. Microbiology. 2014;160:917–28.

Article  CAS  PubMed  Google Scholar 

Golneshin A, Gor MC, Williamson N, Vezina B, Van TTH, May BK, et al. Discovery and characterisation of circular bacteriocin plantacyclin B21AG from Lactiplantibacillus plantarum B21. Heliyon. 2020;6:e04715.

Article  PubMed  PubMed Central  Google Scholar 

Koizumi J, Nakase K, Hayashi N, Nasu Y, Hirai Y, Nakaminami H. Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections. J Glob Antimicrob Resist. 2022;28:151–7.

Article  CAS  PubMed  Google Scholar 

van de Guchte M, van der Vossen JM, Kok J, Venema G. Construction of a lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis. Appl Environ Microbiol. 1989;55:224–8.

Article  PubMed  PubMed Central  Google Scholar 

Morgan-Kiss RM, Cronan JE. The Lactococcus lactis FabF fatty acid synthetic enzyme can functionally replace both the FabB and FabF proteins of Escherichia coli and the FabH protein of Lactococcus lactis. Arch Microbiol. 2008;190:427–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linares DM, Kok J, Poolman B. Genome sequences of Lactococcus lactis MG1363 (revised) and NZ9000 and comparative physiological studies. J Bacteriol. 2010;192:5806–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2007;51:3726–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakase K, Nakaminami H, Toda Y, Noguchi N. Determination of the mutant prevention concentration and the mutant selection window of topical antimicrobial agents against Propionibacterium acnes. Chemotherapy. 2017;62:94–9.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif